Literature DB >> 9399531

Evaluation of serological methods for diagnosis of Puumala hantavirus infection (nephropathia epidemica).

K B Sjölander1, F Elgh, H Kallio-Kokko, O Vapalahti, M Hägglund, V Palmcrantz, P Juto, A Vaheri, B Niklasson, A Lundkvist.   

Abstract

Nephropathia epidemica (NE), Puumala (PUU) virus infection, is a febrile disease which is commonly associated with acute renal impairment. To differentiate NE from other acute febrile illnesses, a rapid and reliable serological diagnosis is important, and a number of different protocols have recently been introduced. In the present report we describe a comparative evaluation of six PUU virus immunoglobulin M (IgM) and seven IgG enzyme-linked immunosorbent assay (ELISA) protocols based on native, Escherichia coli-expressed, or baculovirus-expressed nucleocapsid protein (N). Neutralization and immunofluorescence assays were included for comparison. Equally high sensitivities and specificities were obtained with three mu-capture-based IgM ELISAs using native, baculovirus-expressed, and E. coli-expressed N antigens, respectively, and by an ELISA based on purified E. coli-expressed full-length N adsorbed to solid phase. The assays based on truncated amino-terminal N proteins, including a commercially available PUU virus IgM ELISA, all showed lower sensitivities. For detection of PUU virus-specific IgG, ELISAs based on monoclonal antibody-captured native or baculovirus-expressed N antigens showed optimal sensitivities and specificities, while the assays based on E. coli-expressed N did not detect all PUU virus IgG-positive serum samples. A commercially available PUU virus IgG ELISA based on E. coli-expressed amino-terminal N showed a significantly lower sensitivity than those of all other IgG assays.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9399531      PMCID: PMC230159          DOI: 10.1128/jcm.35.12.3264-3268.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Detection of nephropathia epidemica (Puumala virus)-specific immunoglobulin M by enzyme-linked immunosorbent assay.

Authors:  B Niklasson; T Kjelsson
Journal:  J Clin Microbiol       Date:  1988-08       Impact factor: 5.948

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Serotypes of HFRS (haemorrhagic fever with renal syndrome) virus in East European and Far Eastern U.S.S.R.

Authors:  E A Tkachenko; M A Donets; G V Rezapkin; T K Dzagurova; A P Ivanov; E V Leshchinskaya; I Reshetnikov; S G Drozdov; R A Slonova; G P Somov
Journal:  Lancet       Date:  1982-04-10       Impact factor: 79.321

4.  A novel mu-capture enzyme-linked immunosorbent assay based on recombinant proteins for sensitive and specific diagnosis of hemorrhagic fever with renal syndrome.

Authors:  L G Zöller; S Yang; P Gött; E K Bautz; G Darai
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

5.  Biotin-labeled antigen: a novel approach for detection of Puumala virus-specific IgM.

Authors:  A Ivanov; O Vapalahti; H Lankinen; E Tkachenko; A Vaheri; B Niklasson; A Lundkvist
Journal:  J Virol Methods       Date:  1996-10       Impact factor: 2.014

6.  Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response.

Authors:  O Vapalahti; H Kallio-Kokko; A Närvänen; I Julkunen; A Lundkvist; A Plyusnin; H Lehväslaiho; M Brummer-Korvenkontio; A Vaheri; H Lankinen
Journal:  J Med Virol       Date:  1995-08       Impact factor: 2.327

7.  Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein.

Authors:  O Vapalahti; H Kallio-Kokko; E M Salonen; M Brummer-Korvenkontio; A Vaheri
Journal:  J Gen Virol       Date:  1992-04       Impact factor: 3.891

8.  Immunoglobulin G subclass responses against the structural components of Puumala virus.

Authors:  A Lundkvist; S Björsten; B Niklasson
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

9.  A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the amino-terminus.

Authors:  F Elgh; A Lundkvist; O A Alexeyev; G Wadell; P Juto
Journal:  J Virol Methods       Date:  1996-05       Impact factor: 2.014

10.  Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection.

Authors:  M Brummer-Korvenkontio; A Vaheri; T Hovi; C H von Bonsdorff; J Vuorimies; T Manni; K Penttinen; N Oker-Blom; J Lähdevirta
Journal:  J Infect Dis       Date:  1980-02       Impact factor: 5.226

View more
  24 in total

1.  Diagnostic potential of puumala virus nucleocapsid protein expressed in Drosophila melanogaster cells.

Authors:  K Brus Sjölander; I Golovljova; A Plyusnin; A Lundkvist
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Competitive Homogeneous Immunoassay for Rapid Serodiagnosis of Hantavirus Disease.

Authors:  Satu Hepojoki; Juuso Rusanen; Jussi Hepojoki; Visa Nurmi; Antti Vaheri; Åke Lundkvist; Klaus Hedman; Olli Vapalahti
Journal:  J Clin Microbiol       Date:  2015-05-13       Impact factor: 5.948

3.  Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins.

Authors:  Helga Meisel; Anne Wolbert; Ausra Razanskiene; Andreas Marg; Andris Kazaks; Kestutis Sasnauskas; Georg Pauli; Rainer Ulrich; Detlev H Krüger
Journal:  Clin Vaccine Immunol       Date:  2006-10-04

4.  Utilization of hantavirus antibody results generated over a five-year period to develop an improved serologic algorithm for detecting acute Sin Nombre hantavirus infection.

Authors:  Harry E Prince; Xin Su; Wayne R Hogrefe
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

5.  Hormonal deficiencies during and after Puumala hantavirus infection.

Authors:  S Mäkelä; P Jaatinen; M Miettinen; J Salmi; I Ala-Houhala; H Huhtala; M Hurme; I Pörsti; A Vaheri; J Mustonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-04-16       Impact factor: 3.267

6.  New immunochromatographic rapid test for diagnosis of acute Puumala virus infection.

Authors:  H Hujakka; V Koistinen; P Eerikäinen; I Kuronen; I Mononen; M Parviainen; A Vaheri; A Närvänen; O Vapalahti
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

7.  Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.

Authors:  R L Brocato; M J Josleyn; V Wahl-Jensen; C S Schmaljohn; J W Hooper
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

8.  Nucleocapsid protein of cell culture-adapted Seoul virus strain 80-39: analysis of its encoding sequence, expression in yeast and immuno-reactivity.

Authors:  Jonas Schmidt; Burkhard Jandrig; Boris Klempa; Kumiko Yoshimatsu; Jiro Arikawa; Helga Meisel; Matthias Niedrig; Christian Pitra; Detlev H Krüger; Rainer Ulrich
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

9.  Antigenic characterization of Hantaan and Seoul virus nucleocapsid proteins expressed by recombinant baculovirus: application of a truncated protein, lacking an antigenic region common to the two viruses, as a serotyping antigen.

Authors:  M Morii; K Yoshimatsu; J Arikawa; G Zhou; H Kariwa; I Takashima
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

10.  Expression of the nucleoprotein of the Puumala virus from the recombinant Semliki Forest virus replicon: characterization and use as a potential diagnostic tool.

Authors:  A Billecocq; D Coudrier; F Boué; B Combes; H Zeller; M Artois; M Bouloy
Journal:  Clin Diagn Lab Immunol       Date:  2003-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.